Literature DB >> 19021098

Bile acid ratio in diagnosis of intrahepatic cholestasis of pregnancy.

William M Huang1, Meghana Gowda, James G Donnelly.   

Abstract

We sought to determine if the bile acid ratio of cholic acid to chenodeoxycholic acid (CA:CDCA) is an important component for diagnosis of intrahepatic cholestasis of pregnancy (ICP). We assessed the addition of bile acid CA:CDCA ratio information in diagnosing ICP in a database of patients evaluated for ICP by serum bile acids and hepatic transaminases. Patients were considered to test positive for ICP if there was elevation in total bile acid, CA:CDCA ratio, or transaminase. Of 231 specimens evaluated for ICP with bile acid and transaminases, 17.1% had elevated total bile acids, 29.4% had elevated transaminase, and 8.2% had an elevated bile acid ratio. Most specimens with elevated bile acid ratio also had elevated total bile acid; 35.5% of specimens tested positive by total bile acid and/or transaminases, increasing minimally to 35.9% with bile acid ratio information. Similar results were found using lower total bile acid and bile acid ratio thresholds. The bile acid CA:CDCA ratio contributed little to the diagnosis of ICP. The use of total bile acid and hepatic transaminases without bile acid ratios decreased positive tests by less than 2%.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021098     DOI: 10.1055/s-0028-1103158

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  9 in total

1.  Serum microRNAs as non-invasive diagnostic biomarkers for intrahepatic cholestasis of pregnancy.

Authors:  Yue Zu; Sheng Guo; Guodong Li; Qianyan Gao; Ximin Wang; Chengliang Zhang; Dong Liu
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Bile acids in a multicenter, population-based case-control study of stillbirth.

Authors:  Robert M Silver; Corette B Parker; Robert Goldenberg; Uma M Reddy; Donald J Dudley; George R Saade; Carol J Rowland Hogue; Donald Coustan; Michael W Varner; Matthew A Koch; Deborah Conway; Radek Bukowski; Halit Pinar; Barbara Stoll; Janet Moore; Marian Willinger
Journal:  Am J Obstet Gynecol       Date:  2013-11-08       Impact factor: 8.661

3.  The biochemical diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Adam Morton; Josephine Laurie
Journal:  Obstet Med       Date:  2018-11-04

4.  Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Cristina Manzotti; Giovanni Casazza; Tea Stimac; Dimitrinka Nikolova; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

5.  Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARα(PAC) mice due to dysregulated bile acid synthesis.

Authors:  Hui-Xin Liu; Ying Hu; Samuel W French; Frank J Gonzalez; Yu-Jui Yvonne Wan
Journal:  Oncotarget       Date:  2015

Review 6.  Intrahepatic Cholestasis in Pregnancy: Review of the Literature.

Authors:  Joanna Piechota; Wojciech Jelski
Journal:  J Clin Med       Date:  2020-05-06       Impact factor: 4.241

7.  In search of an accurate evaluation of intrahepatic cholestasis of pregnancy.

Authors:  Manuela Martinefski; Mario Contin; Silvia Lucangioli; Maria Beatriz Di Carlo; Valeria Tripodi
Journal:  Scientifica (Cairo)       Date:  2012-08-01

8.  A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy.

Authors:  Antonín Pařízek; Martin Hill; Michaela Dušková; Libor Vítek; Marta Velíková; Radmila Kancheva; Patrik Šimják; Michal Koucký; Zuzana Kokrdová; Karolína Adamcová; Andrej Černý; Zdeněk Hájek; Luboslav Stárka
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

9.  Bile acids during pregnancy: Trimester variations and associations with glucose homeostasis.

Authors:  Marianne Gagnon; Jocelyn Trottier; S John Weisnagel; Claudia Gagnon; Anne-Marie Carreau; Olivier Barbier; Anne-Sophie Morisset
Journal:  Health Sci Rep       Date:  2021-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.